2017.03.03. Psoriasis treatment efficacy of an Oral INV-17 ROR gamma inhibitor in a mouse Imiquimod Psoriasis model presented at the 2017 AAD Annual Meeting in Orlando, FL

Written By Adam Parks

INV-17 ROR gamma inhibitors for Oral development for Psoriasis demonstrate therapeutic treatment efficacy in a mouse Imiquimod-induced psoriasis disease model.

Read Here +

Adam Parks https://apollocreativeco.com
Previous

2017.09.13. Preclinical POC data in a mouse Psoriasis model following Topical treatment with small molecule INV-17 ROR gamma inhibitor presented at the 2017 EADV Annual Meeting in Geneva, Switzerland
Next

2015.06.11. Efficacy of INV-17 ROR gamma inhibitor in a mouse Lupus model highlighted at the EULAR 2015 meeting in Rome, Italy